Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

anagrelide MeSH Supplementary Concept Data 2025


MeSH Supplementary
anagrelide
Unique ID
C021139
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C021139
Entry Term(s)
6,7-dichloro-1,5-dihydroimidazo(2,1-b)quinazolin-2(3H)-one hydrochloride
Agrelin
Agrylin
BL 4162A
anagrelide hydrochloride
imidazo(2,1-b)quinazolin-2(3H)-one, 6,7-dichloro-1,5-dihydro-, monohydrochloride
Pharm Action
Fibrinolytic Agents
Platelet Aggregation Inhibitors
Registry Numbers
K9X45X0051
VNS4435G39
Related Numbers
VNS4435G39
Previous Indexing
IMIDAZOLES (80-81)
Heading Mapped to
*Quinazolines
Frequency
317
Note
imidazoquinazoline derivative which lowers platelet count probably by inhibiting thrombopoiesis and reduces platelet aggregation; used for thrombocythemia; structure in first source
Source
Thromb Res 15(3-4):373;1979
Indexing Information
Thrombocytosis
Date of Entry
1980/01/01
Revision Date
2016/10/20
anagrelide Preferred
BL 4162A Narrower
Agrylin Narrower
anagrelide hydrochloride Narrower
Agrelin Narrower
page delivered in 0.002s